The Japanese-based company specializes in drug discovery support and drug development, with a focus on creating therapeutic solutions for cancer and inflammatory diseases. Using their proprietary kinase drug discovery platform, QuickScout, Carna Biosciences identifies and develops significant medical values that have the potential to provide effective treatments for patients. By prioritizing research and development, the company aims to improve human health and advance medical science.